EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY 4.0

Pregnancy and Cardiomyopathy: A Prospective Cohort Study

Matthew Cauldwell iD, Mark Johnson iD, Catherine Nelson Piercy iD, Philip Steer iD

BJOG: An International Journal of Obstetrics & Gynaecology · 09.10.2026

DOI: 10.1111/1471-0528.70343 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift BJOG: An International Journal of Obstetrics & Gynaecology, online erschienen am 09.10.2026. Verfasst von Matthew Cauldwell und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Maternal Medicine, St George's Hospital, London, UK. Die Arbeit nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Heart Research UK.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To establish in a national cohort whether the type of cardiomyopathy in women with a prepregnancy diagnosis affected pregnancy outcomes including mortality, gestational age at birth, and delivery type.

Design

Prospective Observational study using United Kingdom Obstetric Surveillance System (UKOSS). Population Women with pre‐pregnancy diagnosis of cardiomyopathy.

Methods

Cases included were defined as women with pre‐pregnancy diagnosis of cardiomyopathy (dilated cardiomyopathy, hypertrophic cardiomyopathy, arrhymogenic right ventricular cardiomyopathy, or Peripartum Cardiomyopathy (PPCM)). Details were notified monthly to UKOSS (1st June 2021 until the 31st May 2024). Main Outcome Measures Obstetric, neonatal, and cardiovascular outcomes.

Results

210 pregnancies in 209 women were identified, 103/209 (49.3%) with dilated cardiomyopathy, 40/209 (19.1%) with hypertrophic cardiomyopathy, 24/209 (11.5%) with previous PPCM, 11/209 (5.3%) with arrhythmogenic right ventricular cardiomyopathy and 31/209 (14.8%) women with ‘other’ cardiomyopathies. Median gestation at delivery in 206 singleton pregnancies was 38.1 (IQR 259–273) weeks; 36/180 (20%) of babies with data recorded were admitted to the neonatal unit. There were no maternal deaths. 10% of women had a documented episode of heart failure and 8% a documented arrhythmia during pregnancy.

Conclusions

Pregnancies in women with cardiomyopathy managed in the UK typically have successful outcomes, consistent with published data. Maternal cardiac complications rate was small. There were no maternal deaths.

Schlagwörter

Stichwörter der Autor:innen

UKOSScardiomyopathypregnancy

Autor:innen und Institutionen

  • Department of Maternal Medicine, St George's Hospital, London, UK.
  • Department of Obstetrics, Chelsea and Westminster Hospital NHS Foundation Trust, London, UK.
  • Maternity Department, Guy's and St Thomas' Hospital NHS Foundation Trust, London, UK.

ORCID-Profile: Matthew Cauldwell, Mark Johnson, Catherine Nelson Piercy, Philip Steer

Förderung

  • Heart Research UK

Zitieren

APA

Cauldwell, M., Johnson, M., Piercy, C. N., & Steer, P. (2026). Pregnancy and Cardiomyopathy: A Prospective Cohort Study. BJOG: An International Journal of Obstetrics & Gynaecology. https://doi.org/10.1111/1471-0528.70343

Vancouver

Cauldwell M, Johnson M, Piercy CN, Steer P. Pregnancy and Cardiomyopathy: A Prospective Cohort Study. BJOG: An International Journal of Obstetrics & Gynaecology. 2026. doi:10.1111/1471-0528.70343

BibTeX
@article{Cauldwell2026,
  author = {Cauldwell, Matthew and Johnson, Mark and Piercy, Catherine Nelson and Steer, Philip},
  title = {Pregnancy and Cardiomyopathy: A Prospective Cohort Study},
  journal = {BJOG: An International Journal of Obstetrics & Gynaecology},
  year = {2026},
  doi = {10.1111/1471-0528.70343}
}
Kostenlos starten →